| scholarly article | Q13442814 |
| P2093 | author name string | M Dolan | |
| C Brunstein | |||
| C Ustun | |||
| T DeFor | |||
| B Trottier | |||
| E D Warlick | |||
| H Pourhassan | |||
| N Bejanyan | |||
| P2860 | cites work | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Q22299206 |
| Defining the intensity of conditioning regimens: working definitions | Q24630836 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| International scoring system for evaluating prognosis in myelodysplastic syndromes | Q28305247 | ||
| Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas | Q33850163 | ||
| Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors | Q33937055 | ||
| Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy | Q34089112 | ||
| A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome | Q34308142 | ||
| Revised international prognostic scoring system for myelodysplastic syndromes | Q34639717 | ||
| Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden | Q34919228 | ||
| Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS. | Q36339459 | ||
| Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type | Q36530726 | ||
| Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome | Q36683757 | ||
| Expanding the role of umbilical cord blood transplantation | Q36759585 | ||
| Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). | Q37169115 | ||
| Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis | Q37301516 | ||
| Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome | Q37656412 | ||
| Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia | Q44548405 | ||
| Non-parametric inference for cumulative incidence functions in competing risks studies. | Q52266832 | ||
| Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & I | Q52981011 | ||
| Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. | Q53094779 | ||
| Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT | Q53166962 | ||
| Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. | Q64988288 | ||
| Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype | Q81769874 | ||
| Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia | Q82236404 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 532-538 | |
| P577 | publication date | 2016-12-12 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes | |
| P478 | volume | 52 |
Search more.